Changes in colon gene expression associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species

BMC Immunology

Volumn 11, Issue , 2010, Pages

  Barnett, Matthew P G ^a   McNabb, Warren C ^a,b   Cookson, Adrian L ^a   Zhu, Shuotun ^c   Davy, Marcus ^d   Knoch, Bianca ^a,e   Nones, Katia ^d   Hodgkinson, Alison J ^f   Roy, Nicole C ^a  

^a AGRESEARCH GRASSLANDS   (New Zealand)

^b MASSEY UNIVERSITY   (New Zealand)

^c THE UNIVERSITY OF AUCKLAND   (New Zealand)

^d THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

^e MASSEY UNIVERSITY   (New Zealand)

^f RUAKURA RESEARCH CENTRE   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; CYTOKINE; SERUM AMYLOID A;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; C57BL 10 MOUSE; C57BL 6 MOUSE; COLITIS; COLON; COMPUTER PROGRAM; CONTROLLED STUDY; DETOXIFICATION; DISEASE ASSOCIATION; ENTERITIS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FATTY ACID METABOLISM; FOOD; GENE EXPRESSION; IMMUNE RESPONSE; INFLAMMATORY DISEASE; INOCULATION; LIPID METABOLISM; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SPECIES; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; CLUSTER ANALYSIS; DNA MICROARRAY; ENTEROCOCCUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INFLAMMATION; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BODY WEIGHT; CLUSTER ANALYSIS; COLON; CYTOKINES; ENTEROCOCCUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERUM AMYLOID A PROTEIN; SIGNAL TRANSDUCTION;

EID: 77954559243     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-11-39     Document Type: Article

References (66)

1. de Buhr MF, Mahler M, Geffers R, Hansen W, Westendorf AM, Lauber J, Buer J, Schlegelberger B, Hedrich HJ, Bleich A. Cd14, Gbp1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analyses. Physiol Genomics 2006, 25(3):426-434. 10.1152/physiolgenomics.00022.2005, 16705022.
2. Yantiss RK, Odze RD. Diagnostic difficulties in inflammatory bowel disease pathology. Histopathology 2006, 48(2):116-132. 10.1111/j.1365-2559.2005.02248.x, 16405661.
3. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001, 357(9272):1925-1928. 10.1016/S0140-6736(00)05063-7, 11425413.
4. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411(6837):603-606. 10.1038/35079114, 11385577.
5. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411(6837):599-603. 10.1038/35079107, 11385576.
6. van Heel DA, Udalova IA, De Silva AP, McGovern DP, Kinouchi Y, Hull J, Lench NJ, Cardon LR, Carey AH, Jewell DP, et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. Hum Mol Genet 2002, 11(11):1281-1289. 10.1093/hmg/11.11.1281, 12019209.
7. Pierik M, Joossens S, Van Steen K, Van Schuerbeek N, Vlietinck R, Rutgeerts P, Vermeire S. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis 2006, 12(1):1-8. 10.1097/01.MIB.0000195389.11645.ab, 16374251.
8. Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, Hocke M, Eitner K, Marx M, Duerig N, Epplen JT. Interleukin-4 and interleukin-4 receptor gene polymorphisms in inflammatory bowel diseases. Genes Immun 2001, 2(5):287-289. 10.1038/sj.gene.6363779, 11528525.
9. Glas J, Torok HP, Tonenchi L, Kapser J, Schiemann U, Muller-Myhsok B, Folwaczny M, Folwaczny C. Association of polymorphisms in the interleukin-18 gene in patients with Crohn's disease depending on the CARD15/NOD2 genotype. Inflamm Bowel Dis 2005, 11(12):1031-1037. 10.1097/01.MIB.0000187574.41290.b1, 16306764.
10. Potocnik U, Ferkolj I, Glavac D, Dean M. Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis. Genes Immun 2004, 5(7):530-539. 10.1038/sj.gene.6364123, 15505619.
11. Ardizzone S, Maconi G, Bianchi V, Russo A, Colombo E, Cassinotti A, Penati C, Tenchini ML, Bianchi Porro G. Multidrug resistance 1 gene polymorphism and susceptibility to inflammatory bowel disease. Inflamm Bowel Dis 2007, 13(5):516-523. 10.1002/ibd.20108, 17260353.
12. Leung E, Hong J, Fraser AG, Merriman TR, Vishnu P, Krissansen GW. Polymorphisms in the organic cation transporter genes SLC22A4 and SLC22A5 and Crohn's disease in a New Zealand Caucasian cohort. Immunol Cell Biol 2006, 84(2):233-236. 10.1111/j.1440-1711.2006.01423.x, 16519742.
13. Silverberg MS, Duerr RH, Brant SR, Bromfield G, Datta LW, Jani N, Kane SV, Rotter JI, Philip Schumm L, Hillary Steinhart A, et al. Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease. Eur J Hum Genet 2007, 15(3):328-335. 10.1038/sj.ejhg.5201756, 17213842.
14. Balish E, Warner T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol 2002, 160(6):2253-2257. 1850822, 12057927.
15. Kennedy RJ, Hoper M, Deodhar K, Erwin PJ, Kirk SJ, Gardiner KR. Interleukin 10-deficient colitis: new similarities to human inflammatory bowel disease. Br J Surg 2000, 87(10):1346-1351. 10.1046/j.1365-2168.2000.01615.x, 11044159.
16. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75(2):263-274. 10.1016/0092-8674(93)80068-P, 8402911.
17. Madsen KL, Malfair D, Gray D, Doyle JS, Jewell LD, Fedorak RN. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis 1999, 5(4):262-270. 10.1002/ibd.3780050405, 10579119.
18. Aharoni R, Kayhan B, Brenner O, Domev H, Labunskay G, Arnon R. Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease. J Pharmacol Exp Ther 2006, 318(1):68-78. 10.1124/jpet.106.103192, 16624971.
19. Berg DJ, Davidson N, Kuhn R, Muller W, Menon S, Holland G, Thompson-Snipes L, Leach MW, Rennick D. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 1996, 98(4):1010-1020. 10.1172/JCI118861, 507517, 8770874.
20. Cohen SL, Moore AM, Ward WE. Flaxseed oil and inflammation-associated bone abnormalities in interleukin-10 knockout mice. J Nutr Biochem 2005, 16(6):368-374. 10.1016/j.jnutbio.2005.01.008, 15936649.
21. McCarthy J, O'Mahony L, O'Callaghan L, Sheil B, Vaughan EE, Fitzsimons N, Fitzgibbon J, O'Sullivan GC, Kiely B, Collins JK, et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003, 52(7):975-980. 10.1136/gut.52.7.975, 1773705, 12801954.
22. Sydora BC, Tavernini MM, Wessler A, Jewell LD, Fedorak RN. Lack of interleukin-10 leads to intestinal inflammation, independent of the time at which luminal microbial colonization occurs. Inflamm Bowel Dis 2003, 9(2):87-97. 10.1097/00054725-200303000-00002, 12769442.
23. Kim SC, Tonkonogy SL, Albright CA, Tsang J, Balish EJ, Braun J, Huycke MM, Sartor RB. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 2005, 128(4):891-906. 10.1053/j.gastro.2005.02.009, 15825073.
24. Kim SC, Tonkonogy SL, Karrasch T, Jobin C, Sartor RB. Dual-association of gnotobiotic IL-10-/- mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis. Inflamm Bowel Dis 2007, 13(12):1457-1466. 10.1002/ibd.20246, 17763473.
25. Jett BD, Huycke MM, Gilmore MS. Virulence of enterococci. Clin Microbiol Rev 1994, 7(4):462-478. 358337, 7834601.
26. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, Rennick DM, Sartor RB. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998, 66(11):5224-5231. 108652, 9784526.
27. Eaton TJ, Gasson MJ. Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. Appl Environ Microbiol 2001, 67(4):1628-1635. 10.1128/AEM.67.4.1628-1635.2001, 92779, 11282615.
28. Sghir A, Gramet G, Suau A, Rochet V, Pochart P, Dore J. Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol 2000, 66(5):2263-2266. 10.1128/AEM.66.5.2263-2266.2000, 101487, 10788414.
29. Finegold SM, Sutter VL, Mathisen GE. Normal indigenous intestinal flora. Human intestinal microflora in health and disease 1983, 3-31. New York: Academic Press, Hentges DJ.
30. Tannock GW, Cook G. Enterococci as members of the intestinal microflora of humans. The enterococci: pathogenesis, molecular biology, and antibiotic resistance 2002, 101-132. Washington, DC.: ASM Press, Gilmore MS.
31. Noble CJ. Carriage of group D streptococci in the human bowel. J Clin Pathol 1978, 31(12):1182-1186. 10.1136/jcp.31.12.1182, 1145528, 107199.
32. Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, Maggi E, Pupilli C, Tonelli F, Romagnani S. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997, 150(3):823-832. 1857889, 9060820.
33. Monteleone G, Monteleone I, Fina D, Vavassori P, Del Vecchio Blanco G, Caruso R, Tersigni R, Alessandroni L, Biancone L, Naccari GC, et al. Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease. Gastroenterology 2005, 128(3):687-694. 10.1053/j.gastro.2004.12.042, 15765404.
34. Roy NC, Barnett MPG, Knoch B, Dommels YEM, McNabb WC. Nutrigenomics applied to an animal model of Inflammatory Bowel Diseases: transcriptomic analysis of the effects of eicosapentaenoic acid- and arachidonic acid-enriched diets. Mutat Res 2007, 622(1-2):103-116.
35. Te Velde AA, De Kort F, Sterrenburg E, Pronk I, Ten Kate FJW, Hommes DW, Van Deventer SJH. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease. Inflammatory Bowel Diseases 2007, 13(3):325-330. 10.1002/ibd.20079, 17206675.
36. Rennick DM, Fort MM. Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2000, 278(6):G829-833.
37. Ruiz PA, Shkoda A, Kim SC, Sartor RB, Haller D. IL-10 gene-deficient mice lack TGF-beta/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis. J Immunol 2005, 174(5):2990-2999.
38. Mudter J, Neurath MF. Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis 2007, 13(8):1016-1023. 10.1002/ibd.20148, 17476678.
39. Guo W, Magnotti LJ, Ding J, Huang Q, Xu D, Deitch EA. Influence of gut microflora on mesenteric lymph cytokine production in rats with hemorrhagic shock. J Trauma 2002, 52(6):1178-1185. disciussion 1185, 10.1097/00005373-200206000-00026, 12045650.
40. Sanchez-Munoz F, Dominguez-Lopez A, Yamamoto-Furusho JK. Role of cytokines in inflammatory bowel disease. World J Gastroenterol 2008, 14(27):4280-4288. 10.3748/wjg.14.4280, 2731177, 18666314.
41. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002, 347(6):417-429. 10.1056/NEJMra020831, 12167685.
42. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003, 3(7):521-533. 10.1038/nri1132, 12876555.
43. Silva MA, Menezes J, Wizman S, Gendron R, Oligny L, Seidman EG. Cytokine tissue levels as markers of disease activity in pediatric Crohn disease. Pediatr Res 2003, 54(4):456-461. 10.1203/01.PDR.0000083002.91602.40, 12840152.
44. Tincani A, Andreoli L, Bazzani C, Bosiso D, Sozzani S. Inflammatory molecules: a target for treatment of systemic autoimmune diseases. Autoimmun Rev 2007, 7(1):1-7. 10.1016/j.autrev.2007.03.001, 17967717.
45. Hansen JJ, Holt L, Sartor RB. Gene expression patterns in experimental colitis in IL-10-deficient mice. Inflamm Bowel Dis 2009, 15(6):890-899. 10.1002/ibd.20850, 2763592, 19133689.
46. Aitken AE, Richardson TA, Morgan ET. Regulation of drug-metabolizing enzymes and transporters in inflammation. Annu Rev Pharmacol Toxicol 2006, 46:123-149. 10.1146/annurev.pharmtox.46.120604.141059, 16402901.
47. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249(4975):1431-1433. 10.1126/science.1698311, 1698311.
48. Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, Hocke M, Eitner K, Marx M, Duerig N, Epplen JT. A polymorphism in the CD14 gene is associated with Crohn disease. Scand J Gastroenterol 2002, 37(2):189-191. 10.1080/003655202753416867, 11843056.
49. Obana N, Takahashi S, Kinouchi Y, Negoro K, Takagi S, Hiwatashi N, Shimosegawa T. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14. Scand J Gastroenterol 2002, 37(6):699-704. 10.1080/00365520212504, 12126249.
50. Narushima Y, Unno M, Nakagawara K, Mori M, Miyashita H, Suzuki Y, Noguchi N, Takasawa S, Kumagai T, Yonekura H, et al. Structure, chromosomal localization and expression of mouse genes encoding type III Reg, RegIII alpha, RegIII beta, RegIII gamma. Gene 1997, 185(2):159-168. 10.1016/S0378-1119(96)00589-6, 9055810.
51. Bohn E, Bechtold O, Zahir N, Frick JS, Reimann J, Jilge B, Autenrieth IB. Host gene expression in the colon of gnotobiotic interleukin-2-deficient mice colonized with commensal colitogenic or noncolitogenic bacterial strains: common patterns and bacteria strain specific signatures. Inflamm Bowel Dis 2006, 12(9):853-862. 10.1097/01.mib.0000231574.73559.75, 16954804.
52. Keilbaugh SA, Shin ME, Banchereau RF, McVay LD, Boyko N, Artis D, Cebra JJ, Wu GD. Activation of RegIIIbeta/gamma and interferon gamma expression in the intestinal tract of SCID mice: an innate response to bacterial colonisation of the gut. Gut 2005, 54(5):623-629. 10.1136/gut.2004.056028, 1774500, 15831905.
53. Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006, 313(5790):1126-1130. 10.1126/science.1127119, 2716667, 16931762.
54. Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, Schnabl B, DeMatteo RP, Pamer EG. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 2008, 455(7214):804-807. 10.1038/nature07250, 2663337, 18724361.
55. Folch-Puy E, Granell S, Dagorn JC, Iovanna JL, Closa D. Pancreatitis-associated protein I suppresses NF-kappa B activation through a JAK/STAT-mediated mechanism in epithelial cells. J Immunol 2006, 176(6):3774-3779.
56. Wijburg OL, Uren TK, Simpfendorfer K, Johansen FE, Brandtzaeg P, Strugnell RA. Innate secretory antibodies protect against natural Salmonella typhimurium infection. J Exp Med 2006, 203(1):21-26. 10.1084/jem.20052093, 2118088, 16390940.
57. Murthy AK, Dubose CN, Banas JA, Coalson JJ, Arulanandam BP. Contribution of polymeric immunoglobulin receptor to regulation of intestinal inflammation in dextran sulfate sodium-induced colitis. J Gastroenterol Hepatol 2006, 21(9):1372-1380.
58. Selby WS, Poulter LW, Hobbs S, Jewell DP, Janossy G. Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis. J Clin Pathol 1983, 36(4):379-384. 10.1136/jcp.36.4.379, 498231, 6339564.
59. Dommels YEM, Butts C, Zhu ST, Davy M, Martell S, Hedderly D, Barnett MPG, Broadley K, Roy NC. Characterization of inflammation in mdr1a-/- mice and identification of related gene expression changes in colonic epithelial cells. Genes Nutr 2007, 2(2):209-223. 10.1007/s12263-007-0051-4, 2474946, 18850176.
60. Tannock GW. Molecular assessment of intestinal microflora. Am J Clin Nutr 2001, 73(2 Suppl):410S-414S.
61. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995, 33(1):24-27. 227872, 7699051.
62. Park EI, Paisley EA, Mangian HJ, Swartz DA, Wu MX, O'Morchoe PJ, Behr SR, Visek WJ, Kaput J. Lipid level and type alter stearoyl CoA desaturase mRNA abundance differently in mice with distinct susceptibilities to diet-influenced diseases. J Nutr 1997, 127(4):566-573.
63. Kruschewski M, Foitzik T, Perez-Canto A, Hubotter A, Buhr HJ. Changes of colonic mucosal microcirculation and histology in two colitis models: an experimental study using intravital microscopy and a new histological scoring system. Dig Dis Sci 2001, 46(11):2336-2343. 10.1023/A:1012334727509, 11713932.
64. Smyth GK. Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor 2005, 397-420. New York: Springer, Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W.
65. Ramakers C, Ruijter JM, Deprez RH, Moorman AF. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 2003, 339(1):62-66. 10.1016/S0304-3940(02)01423-4, 12618301.
66. Nones K, Dommels YE, Martell S, Butts C, McNabb WC, Park ZA, Zhu S, Hedderley D, Barnett MP, Roy NC. The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a-/-) mice, a model of inflammatory bowel diseases. Br J Nutr 2009, 101(2):169-181. 10.1017/S0007114508009847, 18761777.